Bioactive Compounds List
Type Distribution
Max Phase Distribution
Bioactive Compounds List
| Bio ID | Target ID | Target Name | ChEMBL ID | Name | Type | Max Phase | Molecular Weight | Targets | Bioactivities | Molecular Formula | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|
| bio1861 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL2108467 | GINSENG, ASIAN | Unknown | Phase 2 | -- | -- | -- | -- | Details |
| bio1862 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL338604 | C-1311 | Small molecule | Phase 2 | 350.42 | 16.0 | 60.0 | C20H22N4O2 | Details |
| bio1863 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL1201060 | LOXAPINE HYDROCHLORIDE | Small molecule | Phase 4 | 364.28 | -- | -- | C18H19Cl2N3O | Details |
| bio1864 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL3301612 | ENCORAFENIB | Small molecule | Phase 4 | 540.02 | 369.0 | 401.0 | C22H27ClFN7O4S | Details |
| bio1865 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL2108975 | ANCESTIM | Protein | Phase 2 | -- | -- | -- | -- | Details |
| bio1866 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL506569 | LANATOSIDE C | Small molecule | Phase 4 | 985.13 | 111.0 | 161.0 | C49H76O20 | Details |
| bio1867 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL425 | OLSALAZINE | Small molecule | Phase 4 | 302.24 | 46.0 | 132.0 | C14H10N2O6 | Details |
| bio1868 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL216981 | NAVARIXIN | Small molecule | Phase 2 | 397.43 | 21.0 | 68.0 | C21H23N3O5 | Details |
| bio1869 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL2105729 | DABRAFENIB MESYLATE | Small molecule | Phase 4 | 615.68 | -- | -- | C24H24F3N5O5S3 | Details |
| bio1870 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL685 | MEBENDAZOLE | Small molecule | Phase 4 | 295.30 | 202.0 | 1231.0 | C16H13N3O3 | Details |